How is Bendeka different to Treanda?
Although Bendeka and Treanda both contain bendamustine hydrochloride, there are two main differences between them.
The first difference is that it takes less time to administer the same dosage of Bendeka compared to Treanda.
- An infusion of Bendeka can be administered over 10 minutes whereas an infusion of Treanda must be administered over 60 minutes.
The second difference is that Bendeka is compatible with polycarbonate or acrylonitrile-butadiene-styrene (ABS)-containing infusion equipment, and Treanda injection is not.
- Treanda Injection cannot be used with closed system transfer devices (CSTDs), adapters, and syringes containing polycarbonate or acrylonitrile-butadiene-styrene (ABS) as significant absorption of the active ingredient bendamustine to surfaces containing these ingredients will occur.
- This is because Treanda injection contains N, N-dimethylacetamide (DMA), which binds to polycarbonate or acrylonitrile-butadiene-styrene (ABS).
- In addition, only polypropylene syringes with a metal needle and polypropylene hub can be used to withdraw and transfer Treanda Injection into the infusion bag. Polypropylene syringes are translucent in appearance.
Another difference concerns the confusion that exists by having two types of Treanda formulations available: Treanda Injection and Treanda for Injection which is a powder that requires mixing with sterile water before diluting.
The concentration of bendamustine hydrochloride also differs in these preparations.
- In Treanda injection the concentration of bendamustine is 90 mg/mL.
- After reconstituting the concentration of bendamustine in Treanda for injection is 5 mg/mL.
Treanda injection and Treanda for injection should not be mixed or combined.
In 2016, Teva replaced Treanda with Bendeka, although Treanda is still available through Cephalon, a subsidiary company of Teva.
Related questions
- Are lung nodules common after Bendeka & Rituxan therapy?
- Why has Bendeka replaced Treanda?
- How often is Bendeka given and how long does treatment last?
Bendeka Vs Treanda: Similarities
There are many similarities between Bendeka and Treanda:
- Both Bendeka and Treanda contain bendamustine HCl
- Bendeka has the same indications for use as Treanda and may be used to treat chronic lymphocytic leukemia (CLL) or indolent (slow-growing) B-cell non-Hodgkin lymphoma that has progressed despite treatment.
- Bendeka and Treanda have the same side effects.
References
- Bendeka (bendamustine) Teva Pharmaceuticals USA, Inc. https://www.drugs.com/pro/bendeka.html#s-34090-1
- Bendamustine Chemocare. http://chemocare.com/chemotherapy/drug-info/bendamustine.aspx Bendeka (bendamustine) Medical News Today. 2020 https://www.medicalnewstoday.com/articles/bendeka Non-Hodgkin's lymphoma
- Mayo Clinic https://www.mayoclinic.org/diseases-conditions/non-hodgkins-lymphoma/symptoms-causes/syc-20375680
- Mayo Clinic https://www.mayoclinic.org/diseases-conditions/non-hodgkins-lymphoma/symptoms-causes/syc-20375680
- Treanda (bendamustine) [Package Insert] Cephalon, Inc. Revised 11/2019 https://www.drugs.com/pro/treanda.html#s-34067-9
- Treanda (bendamustine) [Package Insert] Cephalon, Inc. Revised 11/2019 https://www.drugs.com/pro/treanda.html#s-34067-9
- Treatment Name: Bendamustine (Bendeka®) + Rituximab Chemoexperts https://www.chemoexperts.com/bendamustine-bendeka-rituximab-rituxan-lymphoma.html
- Teva launches short-time infusion formulation of chemo agent bendamustine Jan. 28, 2016 Teva Pharmaceutical Inc Seekingalpha https://seekingalpha.com/news/3062186-teva-launches-short-time-infusion-formulation-of-chemo-agent-bendamustine
- Center for Drug Evaluation and Research Application number 208194orig1s000 Access Data FDA https://www.accessdata.fda.gov/drugsatfda_docs/nda/2015/208194Orig1s000MedR.pdf
Read next
How will I feel after a Rituxan infusion?
After a Rituxan (rituximab) infusion you may experience certain side effects or adverse reactions that make you feel unwell. Common side effects include nausea, infusion-related reactions, and feeling tired. Continue reading
How long does it take for Rituxan to work?
Patients treated with Rituxan may notice an early response within 7-8 weeks of treatment. Most rheumatoid arthritis patients will notice some improvement in their symptoms, such as improvement in their levels of pain and inflammation, within 16 weeks of starting treatment with Rituxan. Continue reading
What are CHOP and R-CHOP chemotherapy regimens?
CHOP and R-CHOP are two chemotherapy regimens. CHOP contains cyclophosphamide, doxorubicin, vincristine, and prednisone, while R-CHOP adds rituximab. R-CHOP is the standard treatment for most patients with B-cell non-Hodgkin lymphomas, especially DLBCL, due to its superior efficacy.
Continue readingSee also:
Related medical questions
- Does Treanda cause hair loss?
- What is Treanda used for and how does it work?
- What is Bendeka used for?
- How does the drug Rituxan work?
- What is the difference between Truxima and Rituxan?
- What is the success rate of Rituxan (rituximab) in patients with blood cancers?
- Anthracycline Drugs for Chemo: How Do They Work?
- How do you prepare for a Rituxan infusion?
- Does Truxima make you gain weight?
- What causes infusion reactions to rituximab?
- Does ibrutinib cause hair loss?
- Is Truxima a chemotherapy drug?
- Is Adcetris a chemotherapy drug?
- What is Zydelig used for and how does it work?
- What is the difference between Rituxan and Rituxan Hycela?
- What is the success rate of Epkinly?
Drug information
Related support groups
- Bendamustine (7 questions, 13 members)
- Bendeka (5 questions, 3 members)
- Treanda (4 questions, 11 members)
- Non-Hodgkin's Lymphoma (18 questions, 39 members)
- Chronic Lymphocytic Leukemia (CLL) (27 questions, 57 members)